famotidine has been researched along with Anemia, Iron-Deficiency in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 59-year-old man was orally administered rabeprazole, a proton pump inhibitor (PPI), for gastroesophageal reflux disease, after which he gradually developed iron-deficiency anemia." | 3.80 | Iron-deficiency anemia caused by a proton pump inhibitor. ( Chonan, A; Hashimoto, R; Matsuda, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, R | 1 |
| Matsuda, T | 1 |
| Chonan, A | 1 |
1 other study available for famotidine and Anemia, Iron-Deficiency
| Article | Year |
|---|---|
Iron-deficiency anemia caused by a proton pump inhibitor.
Topics: Anemia, Iron-Deficiency; Famotidine; Gastroesophageal Reflux; Humans; Male; Middle Aged; Proton Pump | 2014 |